Carbohydrate count aided by a simulation of postprandial glucose dynamics generated by a mathematical model in people with type 1 diabetes mellitus
ABSTRACT Diabetes mellitus (DM) is one of the most common non-communicable chronic diseases. Its prevalence is increasing, and the increase is expected to be more marked in poor and developing countries. For people with type 1 diabetes mellitus (DM1), insulin is the only medication approved for trea...
- Autores:
-
Builes Montaño, Carlos Esteban
García Tirado, José Fernando
Restrepo Gutierrez, Juan Carlos
Alvarez Zapata, Hernán Darío
Lema Pérez, Laura
Zuleta Tobón, John Jairo
Ramírez Rincón, Alex Humberto
- Tipo de recurso:
- Doctoral thesis
- Fecha de publicación:
- 2024
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/41897
- Acceso en línea:
- https://hdl.handle.net/10495/41897
https://doi.org/10.1016/j.compbiomed.2022.105232
https://doi.org/10.53853/encr.9.4.770
https://doi.org/10.1111/jhn.13017
https://doi.org/10.1371/ journal.pone.0285849
- Palabra clave:
- Sistemas de soporte de decisiones
Decision support systems
Diabetes Mellitus Tipo 1
Diabetes Mellitus, Type 1
Terapia Nutricional
Nutrition Therapy
Predicción
Forecasting
Modelos Matematicos
Mathematical models
Conteo de Carbohidratos
https://lccn.loc.gov/sh86006549
https://id.nlm.nih.gov/mesh/D003922.
https://id.nlm.nih.gov/mesh/D044623
https://id.nlm.nih.gov/mesh/D005544
- Rights
- embargoedAccess
- License
- https://creativecommons.org/licenses/by-nc-sa/4.0/
| Summary: | ABSTRACT Diabetes mellitus (DM) is one of the most common non-communicable chronic diseases. Its prevalence is increasing, and the increase is expected to be more marked in poor and developing countries. For people with type 1 diabetes mellitus (DM1), insulin is the only medication approved for treatment, and for people with type 2 diabetes mellitus (DM2). However, there are new medications; in countries like Colombia, the use of insulin is quite frequent. A treatment based on reducing blood glucose concentration reduces the risk of chronic complications, and carbohydrate counting is the most widely recommended dose calculation technique. Carbohydrate counting is an iterative process for people with DM accompanied by high uncertainty, especially initially. Carbohydrate counting is refined with experience and frequent interventions by doctors and patient support staff. This work aimed to probe whether carbohydrate counting aided by a simulation was better than the traditional technique to estimate insulin dose in people with DM1. To do this, a phenomenological mathematical model of the glucose dynamics in the gastrointestinal system was built to simulate the changes experienced by an individual's blood glucose after a meal. Then, a mobile and simple-to-use solution was developed so that a person could simulate a meal and evaluate the impact of insulin dose estimated by carbohydrate counting. We hypothesized that frequent use of a solution like the one described should result in better glucose control. This hypothesis was tested in a randomized controlled clinical trial. |
|---|
